Article Details

Roche's arthritis drug Actemra scores FDA nod in rare autoimmune disease after partial clinical win

Retrieved on: 2021-03-05 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Roche's arthritis drug Actemra scores FDA nod in rare autoimmune disease after partial clinical win. View article details on hiswai:

Excerpt

Roche's Actemra has become the first biologic that the FDA approved for patients with systemic sclerosis-associated interstitial lung disease.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo